miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A

Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma

(2016) Shaobing Cheng et al.   GENE

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

(2016) Sherry Y. Wu et al.   Nature Communications

Cyclophilin A regulates JNK/p38-MAPK signaling through its physical interaction with ASK1

(2015) Hunsung Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway

(2015) HAI JIN et al.   ONCOLOGY REPORTS

Regulation of growth of human bladder cancer by miR-192

(2015) Yongchao Jin et al.   TUMOR BIOLOGY

BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer

(2013) Fen Hu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways

(2013) Zhengyu Li et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma

(2013) H.W.Z. Khella et al.   CARCINOGENESIS

Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells

(2012) Szu-Ting Lin et al.   Journal of Proteomics

microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer

(2011) YEUNPO CHIANG et al.   Experimental and Therapeutic Medicine

MicroRNA and drug resistance

(2010) J Ma et al.   CANCER GENE THERAPY

miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation

(2010) Valentina Boni et al.   MOLECULAR CANCER THERAPEUTICS

Prolyl Isomerase Cyclophilin A Regulation of Janus-Activated Kinase 2 and the Progression of Human Breast Cancer

(2008) J. Zheng et al.   CANCER RESEARCH

Proteomics Identification of Cyclophilin A as a Potential Prognostic Factor and Therapeutic Target in Endometrial Carcinoma

(2008) Zhengyu Li et al.   MOLECULAR & CELLULAR PROTEOMICS